🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12381+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12381 recruiting trials

NARecruitingNCT06251115

Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC

👨‍⚕️ Jiang Long, MD, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06251778

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

🏥 Paolo Milani📍 1 site📅 Started Jan 2024View details ↗
Phase 2, PHASE3RecruitingNCT06030440

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

👨‍⚕️ Sarina Müller, PD, Universitätsklinikum Erlangen, HNO📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT07142473

Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Jan 2024View details ↗
Enrolling by InvitationNCT07025122

Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease

👨‍⚕️ Petra Hnilicová, PhD Ing, Comenius University📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06243848

Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome

👨‍⚕️ Nuran EYVAZ, MD, Afyonkarahisar Health Sciences University📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06241209

Hemianopsia Rehabilitation After Stroke or Brain Injury

🏥 University of Alberta📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06447025

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

👨‍⚕️ Larimar Therapeutics, Inc., Larimar Therapeutics, Inc.📍 8 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06344260

Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)

👨‍⚕️ Angelo L Vescovi, PhD, Scientific Director Fondazione IRCCS "Casa Sollievo della Sofferenza"📍 4 sites📅 Started Jan 2024View details ↗
RecruitingNCT06572046

STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

👨‍⚕️ Filippo M Santorelli, Dr., IRCCS Fondazione Stella Maris📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT05223816

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

🏥 Virogin Biotech Canada Ltd📍 3 sites📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT06138587

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

👨‍⚕️ Roman Shapiro, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Jan 2024View details ↗
NARecruitingNCT05564936

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

🏥 Ad scientiam📍 19 sites📅 Started Jan 2024View details ↗
RecruitingNCT06477861

The Role of Elastic Power in Predicting the Severity and Mortality in Adult Patients With ARDS Due to Pneumonia

👨‍⚕️ Samar R Mohammed, lecturer of anaesthesia and critical care📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT05886036

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

👨‍⚕️ Raphael E Steiner, University of Texas MD Anderson Cancer Center LAO📍 35 sites📅 Started Jan 2024View details ↗
RecruitingNCT06271512

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

👨‍⚕️ Himal Lal Thakar, MD, bluebird bio, Inc.📍 6 sites📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT06153251

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 19 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06079398

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

👨‍⚕️ Medical Director, MD, Ascendis Pharma A/S📍 17 sites📅 Started Jan 2024View details ↗
RecruitingNCT06976606

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

👨‍⚕️ Lexeo Clinical Trials, Lexeo Therapeutics📍 6 sites📅 Started Jan 2024View details ↗
Phase 1, PHASE2RecruitingNCT06137144

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

🏥 AstraZeneca📍 33 sites📅 Started Jan 2024View details ↗
← PreviousPage 334 of 620Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →